April 22, 2024

Symposium: Accelerating Translation from Discovery to Application

Symposium: Accelerating Translation from Discovery to Application

Titel: Accelerating Translation from Discovery to Application

Termin: 6. Mai 2026

Zeit: 9-13 Uhr

Ort: NMI, Markwiesenstraße 55, 72770 Reutlingen

Teilnahme kostenlos

Mehr Informationen und Anmeldung hier: https://www.nmi.de/en/events/symposium-of-the-biodevcenter


Symposium of the Biological Development Center

Accelerating Translation from Discovery to Application

The development of innovative biologicals often stalls at the transition from academic discovery to clinical application.

The Biologicals Development Center, established by NMI and WSIC with EFRE support, aims to address this challenge by providing comprehensive infrastructure and expertise for the design, production, functionalization, and evaluation of biologicals across therapeutic, diagnostic, and biofunctional domains.

This workshop offers insights into scientific, technological, and manufacturing challenges that shape the future of biologicals. The program includes contributions from the project’s steering committee and invited industry partners.

In addition, the current status of the Center will be presented demonstrating how shared analytical capabilities and structured developability approaches can accelerate early biologicals development.

Together, we explore how coordinated resources and cross‑sector collaboration can strengthen regional innovation and enable biologicals to reach real‑world application faster.

register now

Our latest News

discover more
The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

The Heidelberg and Mannheim University Hospitals consortium has taken first place in the Stern hospital rankings

For the first time in 14 years, there has been a change at the top of the hospital rankings, which are published annually by the MINQ Institute in collaboration with Stern. In its very first year of existence, the Heidelberg and Mannheim University Hospitals Consortium has taken first place. More information in German below: Zusammen […]

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Presentation of the EY German Biotechnology Report 2026 in Heidelberg: Strong Innovation Ecosystems Are Key to Scaling Innovation

Heidelberg, 11 June 2026 – Germany continues to produce world-class science, breakthrough technologies and highly innovative biotechnology companies. However, the challenge is no longer generating innovation – it is creating the conditions that allow innovation to scale. This was one of the central messages emerging from the presentation of the EY German Biotechnology Report 2026, […]

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

CELASC 2026 presentation: Impact of topical lidocaine-prilocaine analgesia on pain-induced grooming after ear notching of mice

Finnish animal welfare legislation (Government Decree 1165/2023) effective as of January 1, 2024, requires establishments to apply “appropriate pain relief” in association with ear notching identification method of laboratory rodents(1). However, there is a lack of scientific evidence whether the benefits of applying analgesia outweigh the additional stress related to handling and drug administration. Our […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp